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Surgical TechniquesIntraoperative indocyanine green fluorescence lymphography to
detect chylous leakage sites after congenital heart surgeryTe-I Chang, MD, Yih-Sharng Chen, MD, PhD, and Shu-Chien Huang, MD, PhD, Taipei, TaiwanChylothorax is a well-known complication that can occur
after complex congenital heart surgery. The majority of pa-
tients can be treated by conservative methods, such as diet
modification, total parenteral nutrition, and octreotide ther-
apy.1 A small number of patients who do not respond to
medical treatment will require surgical thoracic duct liga-
tion. However, there are not many reports discussing solu-
tions for refractory chylothorax after failure of surgical
treatment. We describe a novel technique by incorporating
intraoperative indocyanine green (ICG) fluorescence
lymphography to detect chylous leakage. By subcutaneous
injection of ICG at the groin region, we successfully
detected and sutured a chylous leakage site throughFIGURE 1. Daily chylothorax drainage amount after endocardial cushion def
total parenteral nutrition, 5% dextrose water, or milk feeding. D5W, 5% dextro
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The Journal of Thoracic and Care-sternotomy in a 3-month-old infant with congenital heart
disease who had postoperative refractory chylothorax
despite numerous medical and surgical managements. The
chylous drainage ceased promptly after the operation, and
the method was shown to be precise and specific.CLINICAL SUMMARY
A full-term male infant was diagnosed with an endocar-
dial cushion defect, severe coarctation of the aorta, a large
patent ductal arteriosus, and an aberrant right subclavian ar-
tery. A series of operations, including aortoplasty, patent
ductal arteriosus division, and main pulmonary artery band-
ing, were undertaken after birth. Total corrective surgery of
the endocardial cushion defect was then performed once the
boy reached 3 months of age. The boy presented with
increased chylothorax after the surgery and did not improve
despite fasting and total parenteral nutrition support. Two
thoracotomy approaches of thoracic duct ligation from the
right and left sides were tried but failed to reduce the
chylous drainage (Figure 1).
The chylothorax output remained for weeks without
improvement. To locate the chylous leakage point, we
decided to reexplore the mediastinum on postoperative
day 45. Informed consent was obtained from the patient’s
family, and we adopted the novel technique of intraopera-
tive ICG fluorescence lymphography.ect surgery. The horizontal bar indicates the time periods we administered
se water; ICG, indocyanine green; TPN, total parenteral nutrition.
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FIGURE 2. Intraoperative images showing (A) fluorescence lymphography view with a white arrow identifying a hotspot of ICG leakage after sternotomy.
B, Color image of the same field with a white arrow indicating the leakage fistula. The patient’s head is to the left.
Surgical TechniquesAfter resternotomy, we found no visible chylous leakage
despite meticulous examination. Intraoperative fluores-
cence lymphography was then performed by injecting
2 mL of ICG (Diagnogreen 0.5%; Daiichi Pharmaceutical,
Tokyo, Japan) subcutaneously at the bilateral inguinal re-
gion for absorbance into the lymphatic system. An infrared
camera and a near-infrared excitation light (light-emitting
diode 740 nm) were used to capture the ICG fluorescence
signal image. The inguinal region glowed immediately after
the injection. After approximately 20 minutes, we noticed a
fluorescent hotspot that coincided with a fistula-like struc-
ture at the lateral side of the aorta (Figure 2, A and B).
The fistula was recognized to be a major chylous leakage
point, and after ligation with a pledgeted 4-0 Prolene suture,
there was no further accumulation of lymphatic ICG. The
absence of further leakage was confirmed by applying dry
gauze to the field and checking for any residual ICG stain
on the gauze using the near-infrared camera. The chylo-
thorax drainage ceased after the operation. There was no
chylothorax recurrence after the patient began formula
feeding, and his chest tubes were removed 1 week later.
DISCUSSION
ICG is a hydrophilic tricarbocyanine dye that rapidly
binds to plasma proteins in the body and is mostly incorpo-
rated into the liver and excreted in the bile. When ICG in the
blood is exposed to a near-infrared ray of 760 to 780 nm
wavelength, it generates fluorescence of 800 to 850 nm
wavelength.2 Drug safety is well established with few side
effects. The dye contains sodium iodide and should be
used with caution in patients who are allergic to iodides.
ICG was first used as a fluorescence dye in angiography,
but it has also proven to be advantageous for use in
lymphography because of its highly sensitive fluorescence740 The Journal of Thoracic and Cardiovascular Surgproperties. Hojo and colleagues3 demonstrated a single
dose of 2 mL ICG subcutaneous injection for identification
of sentinel lymph node in breast cancer surgery.
To locate an injured chylous duct, lymphoscintigraphy
with technetium-99m can be considered,4 but this method
does not allow real-time imaging or pinpointing of the exact
leakage site. A preoperative oral ingested heavy cream
method also may be used to identify thoracic lymph ducts;
however, this method provided poor contrast results in com-
parison with ICG fluorescence lymphography in this animal
model.5CONCLUSIONS
Octreotide therapy has been used for chylothorax, but it is
not covered by Taiwan’s National Health Insurance. The
new experimental ICG application in this case proved to
be a precise tool for identification of a chylous leakage
site with great sensitivity and specificity. It has good poten-
tial as an alternative solution in the treatment of patients
with postoperative refractory chylothorax.References
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